Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy

Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy

Bibliographic Details
Main Authors: Katjana S. Schwab, Glen Kristiansen, Alexander Isaak, Stefanie E. A. Held, Annekristin Heine, Peter Brossart
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Oncology
Subjects:
nivolumab ipilimumab
head neck cancer
immunotherapy
Takotsubo cardiomyopathy (TTC)
cardiac toxicity
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00403/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00403/full

Similar Items